Clinical Trials Browser

Enrolling by invitation × Uterine Cervical Neoplasms × 1 year × Clear all

NCT04266093 2026-05-22

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Squamous Intraepithelial Lesions of the Cervix

NCT07594327 2026-05-22

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Enrolling by invitation

21 enrolled

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Sexuality

NCT07218003 2026-05-04

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Phase 1 Enrolling by invitation

149 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06943547 2026-04-30

IMPROVE

Phase NA Enrolling by invitation

1,400 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07325682 2026-01-08

PETCVOCC

Phase NA Enrolling by invitation

30 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07186530 2025-10-30

Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening

Phase NA Enrolling by invitation

500 enrolled

Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT06942286 2025-09-17

Primary HPV Self-Collection in Indonesia

Phase NA Enrolling by invitation

8,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT06786091 2025-06-05

Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment

Phase NA Enrolling by invitation

40 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fecal Incontinence, Pelvic Pain, Pelvic Floor Disorders